Latest Headlines

  1. Cyted Acquires Pathognomics Ltd 10/19/2020

    Cyted Ltd (“Cyted” or “the Company”), a developer and provider of artificial intelligence technology and digital diagnostic infrastructure to enable earlier detection of disease, today announced it has acquired Pathognomics Limited, a provider of digital pathology and clinical diagnostic laboratory services, based in Huntingdon, Cambridgeshire, UK.

  2. Microbix Launches New STI-Related Quality Assessment Products 10/15/2020

    Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, announces its creation, external verification, and registration of new quality assessment products (QAPs™) to help ensure the accuracy of workflows at labs conducting nucleic acid testing for sexually-transmitted Mycoplasma genitalium (Mgen) infections

  3. Safe & Efficient Concentration Of Low Volume Samples 10/15/2020

    BioChromato Inc. reports how the Department of Bioimaging Information Analysis at Gunma University (Japan) is benefiting from the ability of its Smart Evaporator C1 to safely and efficiently concentrate low volume samples

  4. Optimised Microplates For Affinity Binding Assays 10/15/2020

    Porvair Sciences new medium and high bind Krystal (TM) microplates set a new standard for uniform and reproducible capture of a wide range of biomolecules ready for affinity binding assays such as ELISA's

  5. Advancements TV Series To Focus On Innovations In Molecular Laboratory Testing 10/14/2020

    Advancements with Ted Danson will focus on recent developments in molecular and genetic capabilities in an upcoming episode, scheduled for 1Q/2021

  6. Collaboration Between CENTOGENE And U-Diagnostics Increases COVID-19 Testing Capacities In The Netherlands 10/14/2020

    Centogene N.V., a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies, and U-Diagnostics B.V., a Dutch medical laboratory, specialized in analysis in the field of clinical chemistry and hematology, medical microbiology, medical immunology, and pathological diagnostics, today announced that they have joined forces to provide increased COVID-19 testing to communities throughout the Netherlands

  7. miR Scientific Announces FDA Breakthrough Device Designation For Its Prostate Cancer Liquid Biopsy Test 10/13/2020

    miR Scientific, LLC, a healthcare company whose purpose is to transform global cancer management by providing early and highly accurate detection, characterization and monitoring of disease, announced today that it has received Breakthrough Device Designation by the U.S Food & Drug Administration for its miR Sentinel™ PCC4 Assay (miR Sentinel™ Prostate Test)

  8. The Importance Of Laboratory Developed Tests In Diagnosing COVID-19 10/13/2020

    Laboratory developed tests play a vital role in getting patients accurate diagnoses and effective care, and at no time has their importance been clearer than during the current pandemic

  9. COVID-19 Rapid Test Has Successful Lab Results, Research Moves To Next Stages 10/13/2020

    Rapid detection of the SARS-CoV-2 virus, in about 30 seconds following the test, has had successful preliminary results in Mano Misra’s lab at the University of Nevada, Reno

  10. BioGX Announces FDA Emergency Use Authorization Submission Of Extraction-Free Direct RT-PCR Test For COVID-19 10/13/2020

    BioGX, a molecular diagnostics solutions company, announced FDA Emergency Use Authorization (EUA) submission of an extraction-free, direct sample addition RT-PCR test for detection of SARS-CoV-2 viral RNA in patients suspected of COVID-19